Drug data last refreshed 6m ago · AI intelligence enriched 1w ago
ALAVERT (loratadine) is an oral antihistamine available as an orally disintegrating tablet, used to treat allergic rhinitis and urticaria. It works by blocking H1 receptors to reduce histamine-mediated allergic symptoms. The product targets patients seeking non-sedating allergy relief with convenient dosing.
Product is in LOE transition phase with moderate competitive pressure (30%), indicating shrinking margins and likely team consolidation in coming years.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu
A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico
A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure
A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets
A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets
Worked on ALAVERT at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
ALAVERT currently shows zero linked job openings, reflecting its LOE-approaching status and mature market position with limited growth trajectory. Career opportunities are primarily in commercial efficiency, generics defense, and market access roles rather than growth-oriented positions.